Imbalances of Regional Pulmonary Ventilation in Patients With Post-acute-COVID-19

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorJan-Christoph Lewejohann

About this trial

Investigation of the correlation of CT-morphological changes of the lung compared to regional ventilation distribution on electrical impedance tomography in patients with post-acute-Covid-19 symptoms.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

all patients undergoing a Chest CT due to suspected post-acute-Covid-19-syndrome

>18 years

informed consent.

Disqualifiers

trauma patients and patients with unstable spinal injuries or fractures

patients with an BMI over 50

patients with uncontrolled body movements

Patients with a pacemaker

Trial population

All patients presenting to the post-COVID-19 outpatient clinic are screened.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • additional EIT Measurement

    Diagnostic test

    Patients who receive standard CT and pulmonary function testing also receive electroimpedance tomography measurement. The lunghealthy Patients in the control group only receive a EIT.

Treatment groups

50 Participants
are divided into 2 treatment groups
Group A: Control cohort0 interventions
Group B: Case cohort1 intervention

Trial outcomes

Primary outcomes

1

Correlation between tomography and electroimpedance tomography

The primary study objective is to match CT morphological changes in regional ventilation in post-COVID patients and/or changes in lung function examination with changes that can be visualized by electroimpedance tomography.

Time frame
until May 2022

Secondary outcomes

1

Correlation between lung function testing and electroimpedance tomography

Time frame
until May 2022

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Jan-Christoph Lewejohann

Lead sponsor

Jena University Hospital

Sponsor institution

This trial is not recruiting at the moment. You can still explore other options: